Trump Threatens 100% Drug Tariffs, Pharma Asked to Build Hospitals on American Soil
KEY POINTS
- •On Thursday, the Trump administration imposed 100% tariffs on patented pharmaceuticals to pressure companies into price deals and reshoring manufacturing.
- •Thirteen drugmakers made 'most-favored nation' pricing agreements last year after tariff threats, with full exemption for firms building drugs in the U.S.
- •Tariffs on aluminum, steel, and copper were adjusted due to foreign exporters underreporting costs, with metals tariffs now based on American buyer prices.
In a masterstroke of economic subtlety, the Trump administration announced Thursday tariffs soaring to 100% on patented drugs, pressuring 13 Big Pharma giants to sign 'most-favored nation' deals last year—essentially 'bedrock bargains' for America’s overpriced meds. If companies pledge to produce drugs stateside, like Saint Andrew on a pharma hill, tariffs drop to a mere 20%, or a God’s grace exemption if combined with price promises. Japan, South Korea, EU, and Switzerland pharma execs face tariff rates based on pre-existing trade deals—guess who’s winning the corporate favoritism lottery? Oh, and aluminum, steel, and copper tariffs got 'tweaked' by Commerce Secretary Howard Lutnick because foreign exporters had been sneaky, declaring production costs lower than my New Year’s resolution to go to the gym. These tariffs kick in after 120 days for pharma leviathans, 180 for smaller minions, proving tariffs and bureaucracy can be the new wellness plan.
Share the Story
(1 of 3)Source: Axios | Published: 4/2/2026 | Author: Courtenay Brown